These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 19506585)

  • 1. The socioeconomic burden of SLE.
    Lau CS; Mak A
    Nat Rev Rheumatol; 2009 Jul; 5(7):400-4. PubMed ID: 19506585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The economic burden of systemic lupus erythematosus.
    Panopalis P; Clarke AE; Yelin E
    Best Pract Res Clin Rheumatol; 2012 Oct; 26(5):695-704. PubMed ID: 23218432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The socioeconomic burden of systemic lupus erythematosus: state-of-the-art and prospects.
    Zhu TY; Tam LS; Li EK
    Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):53-69. PubMed ID: 22280197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The humanistic and economic burden of systemic lupus erythematosus : a systematic review.
    Meacock R; Dale N; Harrison MJ
    Pharmacoeconomics; 2013 Jan; 31(1):49-61. PubMed ID: 23329592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life in patients with systemic lupus erythematosus: a Spanish study based on patient reports.
    Román Ivorra JA; Fernández-Llanio-Comella N; San-Martín-Álvarez A; Vela-Casasempere P; Saurí-Ferrer I; González-de-Julián S; Vivas-Consuelo D
    Clin Rheumatol; 2019 Jul; 38(7):1857-1864. PubMed ID: 30820696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the patterns of care, access, and direct cost of systemic lupus erythematosus in Brazil: findings from the Macunaíma study.
    de Abreu MM; Monticielo OA; Fernandes V; Rodrigues DLAS; da Silva CAL; Maiorano AC; Beserra FDS; Lamarão FRM; de Veras BMG; David N; Araújo M; Alves MCR; Stocco MA; Lima FM; Borret E; Gasparin AA; Chapacais GF; Bulbol GA; da Silva Lima D; da Silva NJM; Freitas MMC; Bica BERG; de Lima DSN; das Chagas Medeiros MM
    Adv Rheumatol; 2024 Apr; 64(1):30. PubMed ID: 38641825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world medication use and economic outcomes in incident systemic lupus erythematosus patients in the United States.
    Kariburyo F; Xie L; Sah J; Li N; Lofland JH
    J Med Econ; 2020 Jan; 23(1):1-9. PubMed ID: 31589081
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of systemic lupus erythematosus on burden of illness and work productivity in the United States.
    Garris C; Oglesby A; Sulcs E; Lee M
    Lupus; 2013 Sep; 22(10):1077-86. PubMed ID: 23920376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic lupus erythematosus--disease impact on patients.
    Macejová Z; Záriková M; Oetterová M
    Cent Eur J Public Health; 2013 Sep; 21(3):171-3. PubMed ID: 24344545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct health system costs for systemic lupus erythematosus patients in Alberta, Canada.
    Fatoye F; Gebrye T; Svenson LW
    PLoS One; 2021; 16(5):e0251409. PubMed ID: 33961687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The economic burden of systemic lupus erythematosus in Asia: the current state.
    Mak A
    Lupus; 2010 Oct; 19(12):1442-6. PubMed ID: 20947555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The global burden of SLE: prevalence, health disparities and socioeconomic impact.
    Carter EE; Barr SG; Clarke AE
    Nat Rev Rheumatol; 2016 Oct; 12(10):605-20. PubMed ID: 27558659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres.
    Zink A; Fischer-Betz R; Thiele K; Listing J; Huscher D; Gromnica-Ihle E; Specker C; Schneider M;
    Lupus; 2004; 13(7):529-36. PubMed ID: 15352425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drivers of cost and health-related quality of life in patients with systemic lupus erythematosus (SLE): a Swedish nationwide study based on patient reports.
    Bexelius C; Wachtmeister K; Skare P; Jönsson L; Vollenhoven Rv
    Lupus; 2013 Jul; 22(8):793-801. PubMed ID: 23761101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socioeconomic consequences of systemic lupus erythematosus.
    Barber MRW; Clarke AE
    Curr Opin Rheumatol; 2017 Sep; 29(5):480-485. PubMed ID: 28520683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic burden of systemic lupus erythematosus flares and comorbidities in a commercially insured population in the United States.
    Narayanan S; Wilson K; Ogelsby A; Juneau P; Durden E
    J Occup Environ Med; 2013 Nov; 55(11):1262-70. PubMed ID: 24202242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct and indirect costs to employers of patients with systemic lupus erythematosus with and without nephritis.
    Carls G; Li T; Panopalis P; Wang S; Mell AG; Gibson TB; Goetzel RZ
    J Occup Environ Med; 2009 Jan; 51(1):66-79. PubMed ID: 19136875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of systemic lupus erythematosus on employment and work productivity: data from a large cohort in the southeastern United States.
    Drenkard C; Bao G; Dennis G; Kan HJ; Jhingran PM; Molta CT; Lim SS
    Arthritis Care Res (Hoboken); 2014 Jun; 66(6):878-87. PubMed ID: 24339382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of systemic lupus erythematosus on oral health-related quality of life.
    Corrêa JD; Branco LGA; Calderaro DC; Mendonça SMS; Travassos DV; Ferreira GA; Teixeira AL; Abreu LG; Silva TA
    Lupus; 2018 Feb; 27(2):283-289. PubMed ID: 28679308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study.
    Mok CC; Ho LY; Cheung MY; Yu KL; To CH
    Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.